Skip to main content
Clinical Trials/NL-OMON24989
NL-OMON24989
Recruiting
Not Applicable

Shared decision making in patients with Castration-Resistant Prostate Cancer - The impact of implementation of a treatment decision aid in CRPC patients

Elisabeth- TweeSteden ZiekenhuisPostbus 901515000 LC Tilburg0 sites168 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Shared decision making, decision aid, prostate cancer, CRPC
Sponsor
Elisabeth- TweeSteden ZiekenhuisPostbus 901515000 LC Tilburg
Enrollment
168
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Elisabeth- TweeSteden ZiekenhuisPostbus 901515000 LC Tilburg

Eligibility Criteria

Inclusion Criteria

  • Men that are newly diagnosed with CRPC. CRPC is defined as any cancer progression under maximal hormonal treatment with anti\-androgens and/or LHRH agonist or antagonist (when three consecutive rises of PSA are observed at castrate serum levels of testosterone (\< 50 ng/dL or \<1\.7 nmol/L) and/or progression of osseous lesions is shown))
  • \- Patients are eligible for at least two treatment options

Exclusion Criteria

  • \- In the case of a second opinion the patient will not be included if the first opinion was obtained in one of the other involved hospitals and vice versa
  • \- Patients who do not have sufficient knowledge of the Dutch language

Outcomes

Primary Outcomes

Not specified

Similar Trials